Converting Ceftriaxone from 50 mg/kg Every 12 Hours to 100 mg/kg Once Daily
You can safely switch from ceftriaxone 50 mg/kg every 12 hours to 100 mg/kg once daily (maximum 4 g) by simply discontinuing the twice-daily regimen and administering the full once-daily dose at the next scheduled dosing time. This conversion maintains the same total daily dose while leveraging ceftriaxone's favorable pharmacokinetic properties.
Rationale for Once-Daily Dosing
Ceftriaxone has unique pharmacokinetic characteristics that make once-daily dosing highly effective:
- Long elimination half-life: 5.8-8.7 hours in healthy subjects, and 4.3-4.6 hours even in pediatric patients with meningitis 1
- High protein binding: 85-95% bound to plasma proteins, creating a reservoir effect 1
- Excellent CSF penetration: Achieves therapeutic concentrations in cerebrospinal fluid with once-daily dosing 2, 1
Guideline-Supported Dosing Regimens
Multiple authoritative guidelines explicitly endorse both dosing approaches as equivalent:
- IDSA guidelines recommend for infants and children: "50-75 mg/kg/day divided every 12-24 h" 2
- AHA Endocarditis guidelines state: "Ceftriaxone 100 mg/kg per 24 h IV/IM in 1 dose" for pediatric patients 3
- Lyme Disease guidelines specify: "50-75 mg/kg intravenously per day in a single dose (maximum, 2 g)" 4
- FDA labeling approves: "50 to 75 mg/kg, given in divided doses every 12 hours" OR once-daily administration for various indications 1
Clinical Evidence Supporting Once-Daily Dosing
Recent pharmacokinetic modeling demonstrates that once-daily dosing is actually superior to twice-daily dosing for achieving pharmacodynamic targets 5. In a 2024 study of children with meningitis:
- For MIC 1 mg/L (common meningitis pathogens): Once-daily achieved 88% PTA vs. 53% for twice-daily at 24 hours
- Both regimens achieved 100% PTA at steady state
- Once-daily dosing reached therapeutic targets earlier 5
Historical clinical studies confirm excellent outcomes with once-daily dosing:
- 96-100% clinical cure rates in serious pediatric infections 6, 7
- 98% bacteriological cure rate in meningitis with once-daily dosing 7
- CSF sterilization in 96% of bacterial meningitis cases 7
Practical Conversion Steps
- Calculate the once-daily dose: 100 mg/kg (maximum 4 g for serious infections, 2 g for most other infections)
- Timing: Administer at the time of the next scheduled dose
- No overlap needed: Simply discontinue the twice-daily regimen
- Infusion duration:
- Standard: 30 minutes for most patients
- Neonates: 60 minutes to reduce bilirubin encephalopathy risk 1
Important Caveats
Contraindications for once-daily dosing:
- Hyperbilirubinemic neonates (especially premature) - ceftriaxone is contraindicated 1
- Neonates ≤28 days requiring calcium-containing IV solutions 1
Maximum doses:
- Meningitis: 100 mg/kg/day (maximum 4 g) 2, 1
- Other serious infections: 50-75 mg/kg/day (maximum 2 g) 2, 1
Monitoring considerations:
- No dose adjustment needed for renal or hepatic impairment up to 2 g/day 1
- Watch for rare but serious immune hemolytic anemia (24% mortality in historical cases, though declining) 8
Why Once-Daily is Preferred
The once-daily regimen offers multiple advantages without compromising efficacy:
- Convenience: Easier administration, particularly for outpatient parenteral therapy
- Earlier target attainment: Achieves therapeutic CSF concentrations faster 5
- Equivalent outcomes: No difference in mortality or sequelae between dosing regimens 9
- Cost-effective: Reduces nursing time and supplies
The conversion is straightforward: stop the 50 mg/kg q12h dosing and begin 100 mg/kg q24h at the next scheduled dose time, ensuring the total daily dose does not exceed 4 g for meningitis or 2 g for most other indications 2, 1.